A phase Ib/II study of cetuximab and pembrolizumab in RAS-wt mCRC.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: Roswell Park Comprehensive Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2907290230
